THC Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023
For the nine months, net loss was USD 0.354095 million compared to USD 1.87 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.06 a year ago.